Skip to main content

A Phase 2, Open-Label Study Investigating the Safety and Efficacy of Psilocybin-Assisted Therapy for Sexual Assault-Related Posttraumatic Stress Disorder (PTSD)

Un estudio de fase 2, abierto, para explorar la eficacia, la seguridad y la tolerabilidad de la terapia asistida con psilocibina en mujeres con trastorno de estrés postraumático (TEPT) relacionado con agresión sexual.

Status
recruiting
Phase
Phase 2
Institution
Sunstone Medical
Principal investigator
Manish Agrawal, MD, MSC
Start date
2026-05-23
End date
2028-05-01
Registry ID
NCT06902974

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.